相关实验视频

Updated: Jul 2, 2025

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

视网膜疾病的多能干细胞衍生模型:阐明病因,评估新疗法,估计毒性

Marzena Kurzawa-Akanbi¹, Nikolaos Tzoumas¹, Julio C Corral-Serrano²

¹Biosciences Institute, Newcastle University, UK.

Progress in retinal and eye research

|February 18, 2024

概括

多能干细胞 (PSC) 提供了一个可扩展的解决方案,用于生成视网膜细胞以建模视网膜退行性疾病. 这种方法有助于开发有效的治疗方法和理解视力丧失.

科学领域:

眼科和再生医学眼科和再生医学
干细胞生物学和疾病建模

背景情况:

退行性视网膜疾病在全球范围内导致严重的失明,目前的高成本疗法只能使少数人受益.
有效的治疗需要更好地了解视网膜疾病,需要体外模型来复制病理和药物发现.
多能干细胞 (PSC) 为产生多种视网膜细胞类型提供了一种可再生的来源.

研究的目的:

审查PSCs产生的光受体和视网膜色素表皮细胞 (RPE) 的生成.
探索PSC衍生的视网膜模型用于疾病建模,治疗测试,生物标志物识别和毒性研究.
讨论基于PSC的视网膜研究的挑战和未来方向.

主要方法:

对PSC分化成视网膜细胞的现有文献的综述.
分析疾病建模,药物发现和实验治疗中的应用.
讨论包括可扩展性,标准化和复杂有机体系统的需求在内的挑战.

主要成果:

可以将PSC分化为对光敏感的视网膜组织,包括光受体和RPE.
这些PSC衍生模型对体外疾病建模和临床前测试有前途.
实现可扩展性,标准化和结合血管系统和免疫细胞等关键元素仍然是关键挑战.

结论:

来自PSC的视网膜模型是促进退行性视网膜疾病的理解和治疗的宝贵工具.
未来的研究应该专注于改善模型的复杂性,结合血管和免疫细胞,并实施高通量自动化.
先进的微生理系统对于充分捕捉视网膜组织相互作用至关重要.

关键词:

在这个过程中,AMD是AMD.反意义的寡核化物.生物标志物生物标志物 CEP29090 CEP29090 CEP29090 CEP29090 CEP29090 CEP29090 CEP29090 CEP29090 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 克里斯普尔-Cas9是什么意思西里亚 (Cilia) 是一个小体.欧洲社会委员会 (ESCs) 是一个欧洲社会委员会.基因治疗是一种基因疗法.梅拉斯 (MELAS) 是一种葡萄酒.线粒体中的线粒体.对于PRPF来说,这是一个很好的选择.公共服务中心 (PSCs) 的服务.在 RP RP 里面.在 RPE RPE 的情况下,视网膜 (retina) 是一个视网膜.视网母细胞瘤是一种视网母细胞瘤.有毒性有毒性这些是iPSCs.

更多相关视频

Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells

Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells

Published on: April 12, 2021

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Published on: December 9, 2022

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.